Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

USMedicalMarijuana.net Reports Substantial Potential Increase in Tax Dollars Due to Marijuana Legalization
  • USA - English


News provided by

USMedicalMarijuana.net

Oct 24, 2014, 18:30 ET

Share this article

Share toX

Share this article

Share toX


San Francisco, CA (PRWEB) October 24, 2014 -- Numerous states, at least 17 municipalities, and one U.S. territory will vote on whether or not to legalize marijuana for either medical or recreational purposes on November 4. USMedicalMarijuana.net reports a tax revenue increase potentially amounting to billions of dollars will result after legalization.

A conservative estimate of $3 billion in marijuana tax revenue could be potentially made if the drug is legalized in the upcoming elections for drug policy reform

Post this

A recent cannabis tax projection study was conducted by NerdWallet Finance showed that when combining states such as Florida, Alaska, Oregon, Washington, D.C. and others, a conservative estimate of $3 billion in marijuana tax revenue could be potentially made if the drug is legalized in the upcoming elections for drug policy reform. According to NerdWallet the state of California alone has potential to generate over $519 million - an amount almost covering the entire California Department of Parks and Recreation budget for 2013.

In Oregon, Portland City Council has been meeting to discuss whether to join the other 17 Oregon cities in preemptively putting a tax on marijuana. If they proceed with their proposed plan to put 10 percent tax on recreational marijuana, Portland could generate anywhere from $1.7 million and $4 million in annual revenue based on their sales and revenue forecasts. The city council, however, made a unanimous decision to discard the proposed 5 percent tax on medical marijuana.

Colorado was the first state to legalize the sale of recreational marijuana in the U.S., and is expected to rake in anywhere from $60 million to $70 million in taxes on the sales of marijuana this year. In the first six months of 2014, the state has already collected over $25 million in taxes of legal pot sales.

Among the top states looking to legalize marijuana on November 4 are Florida, Oregon, and Alaska.

Florida’s Amendment 2 is the only statewide medical marijuana initiative on the ballot this year, which would make it the first southern state to adopt a law on medical marijuana. Earlier this year, Florida passed a very limited law on medical marijuana, allowing a narrow pool of qualified patients to use a marijuana strain low in THC - the drug’s psychoactive ingredient - for medical purposes. Amendment 2 will legalize marijuana as a form of treatment for debilitating medical conditions like multiple sclerosis, cancer, hepatitis C, HIV, AIDS, Parkinson’s disease, Crohn’s disease, and glaucoma.

The passage of Measure 91 in Oregon will make it the third state to legalize marijuana for adults outright. The state’s initiative will create a statewide system that regulates production and sales, and will legalize possession of marijuana in small amounts for individuals 21 years old and above. Similar to Colorado’s law, adults will also be allowed to cultivate small amounts of marijuana under controlled circumstances. Measure 91 will tax marijuana at the point of sales at $35 per ounce.

Since the 1970s, the Alaska Constitution has allowed for the possession and cultivation of marijuana in small amounts for personal use in a private residence. In fact, it was among the first states alongside Oregon to legalize marijuana for medical purposes in 1998. The statewide Measure 2 initiative that legalizes marijuana for adult use is closely based on Colorado’s Amendment 64, and also contains several elements from Oregon’s potential law. Its passage will tax marijuana at the point of sales at $50 per ounce, and will make Alaska the first red state with full marijuana legalization.

Although the District of Columbia already adopted a marijuana decriminalization law earlier this year, the DC Cannabis Campaign (dcmj.org) believes that the measure does not go far enough. Initiative 71 will make it legal for adults to cultivate and possess marijuana in small amounts, and even gift marijuana to adults 21 years old and above.

U.S. territory Guam, like Florida, will also be voting on the legalization of medical marijuana to treat debilitating conditions such as cancer, multiple sclerosis, glaucoma, epilepsy, and arthritis. Their ballot initiative would also permit dispensaries regulated by the Department of Public Health and Social Services.

USMedicalMarijuana.net is a website that aims to inform visitors on the happenings in the marijuana industry in North America. The site contains the latest on cannabis legislation, implications, and market trend developments.

USMedicalMarijuana.net is part of a portfolio of cannabis industry sites which includes CaliforniaMedicalMarijuana.biz (California cannabis news), NewYorkMedMarijuana.com (New York cannabis news) and MichiganMedicalMarijuana.biz (Michigan cannabis
news).

Companies seeking exposure on USMedicalMarijuana.net can contact editorial(at)greenrushreview(dot)com for more information.

Paul Deriso, USMedicalMarijuana.net, http://www.usmedicalmarijuana.net, +1 (925) 452-6952, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.